- Home
- HSTM vs AURA Comparison
HSTM vs AURA Comparison
Compare HSTM & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HSTM | AURA |
|---|---|---|
| Founded | 1990 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 700.0M | 713.4M |
| IPO Year | 1999 | 2021 |
Fundamental Metrics
Financial Performance| Metric | HSTM | AURA |
|---|---|---|
| Price | $25.24 | $6.63 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $28.00 | $20.00 |
| AVG Volume (30 Days) | 234.4K | ★ 442.7K |
| Earning Date | 05-04-2026 | 05-08-2026 |
| Dividend Yield | ★ 0.66% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.20 | N/A |
| Revenue | ★ $304,064,000.00 | N/A |
| Revenue This Year | $9.45 | N/A |
| Revenue Next Year | $5.12 | N/A |
| P/E Ratio | $126.45 | ★ N/A |
| Revenue Growth | ★ 4.26 | N/A |
| 52 Week Low | $19.50 | $4.73 |
| 52 Week High | $29.59 | $9.54 |
Technical Indicators
Market Signals| Indicator | HSTM | AURA |
|---|---|---|
| Relative Strength Index (RSI) | 62.52 | 32.78 |
| Support Level | $25.00 | $5.33 |
| Resistance Level | $26.01 | $7.04 |
| Average True Range (ATR) | 0.84 | 0.35 |
| MACD | 0.04 | -0.15 |
| Stochastic Oscillator | 80.84 | 4.56 |
Price Performance
Historical ComparisonAbout HSTM HealthStream Inc.
HealthStream Inc provides SaaS based applications for healthcare organizations all designed to improve business and clinical outcomes by supporting the people who deliver patient care. The company is focused on helping individuals and organizations in healthcare meet their ongoing learning, clinical development, credentialing, and scheduling needs. It also provides its solutions to nursing schools and nursing students.
About AURA Aura Biosciences Inc.
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.